Drug Trial Radar · NCT07287670
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
85
Planned (sponsor's estimate)
Start
Apr 16, 2026
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Mediar TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Conditions
- Diffuse Cutaneous Systemic Sclerosis
Interventions
MTX-474Biological
Dosage level: 4 mg/kg Unit dose strength: 50mg/ml MTX-474 is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds the human EphrinB2 with high specificity and high affinity. MTX-474 is being developed as a therapy for patients with systemic sclerosis (SSc).
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Modified Rodnan Skin Score (mRSS)Time frame: Baseline to week 24
Locations
58 sites in 10 countries. Site status is shown where the registry gives one.
EncompaSSc site in Phoenix, AZ
Phoenix, Arizona · Not yet recruiting
EncompaSSc site in La Jolla, CA
La Jolla, California · Not yet recruiting
EncompaSSc site in Loma Linda, CA
Loma Linda, California · Not yet recruiting
University of California Los Angeles Scleroderma Center
Los Angeles, California · Recruiting
NewportNativeMD, Inc.
Newport Beach, California · Recruiting
EncompaSSc site in Palo Alto, CA
Palo Alto, California · Not yet recruiting
University of Colorado Center for Lungs/Breathing/Scleroderma Clinic
Aurora, Colorado · Recruiting
Clinical Research of West Florida
Clearwater, Florida · Recruiting
Sarasota Arthritis Center
Sarasota, Florida · Recruiting
Clinical Research of West Florida
Tampa, Florida · Recruiting
EncompaSSc site in Kansas City, KS
Kansas City, Kansas · Not yet recruiting
Johns Hopkins University
Baltimore, Maryland · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Boston Medical Center
Boston, Massachusetts · Recruiting
EncompaSSc site in Minneapolis, MN
Minneapolis, Minnesota · Not yet recruiting
NYU Langone Health
Brooklyn, New York · Recruiting
EncompaSSc site in Cleveland, OH
Cleveland, Ohio · Not yet recruiting
The University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma · Recruiting
EncompaSSc site in Philadelphia, PA
Philadelphia, Pennsylvania · Not yet recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Recruiting
Stryde Research - DFW
Allen, Texas · Recruiting
Baylor Scott & White Research Institute
Dallas, Texas · Recruiting
EncompaSSc site in Houston, TX
Houston, Texas · Not yet recruiting
Griffith University (Clinical Trial Unit)
Southport, Queensland, Australia · Recruiting
Veracity Clinical Research
Woolloongabba, Queensland, Australia · Recruiting
Austin Health
Heidelberg, Victoria, Australia · Recruiting
EncompaSSc site in La Tronche, France
La Tronche, France · Not yet recruiting
EncompaSSc site in Montpellier, France
Montpellier, France · Not yet recruiting
EncompaSSc site in Paris, France
Paris, France · Not yet recruiting
EncompaSSc site in Strasbourg, France
Strasbourg, France · Not yet recruiting
EncompaSSc site in Toulouse, France
Toulouse, France · Not yet recruiting
EncompaSSc site in Vandœuvre-lès-Nancy, France
Vandœuvre-lès-Nancy, France · Not yet recruiting
EncompaSSc site in Ancona, Italy
Ancona, Italy · Not yet recruiting
EncompaSSc site in Catania, Italy
Catania, Italy · Not yet recruiting
EncompaSSc site in Genoa, Italy
Genoa, Italy · Not yet recruiting
EncompaSSc site in Milan, Italy
Milan, Italy · Not yet recruiting
EncompaSSc site in Modena, Italy
Modena, Italy · Not yet recruiting
EncompaSSc site in Roma, Italy
Roma, Italy · Not yet recruiting
EncompaSSc site in Groningen, Netherlands
Groningen, Netherlands · Not yet recruiting
Aotearoa Clinical Trials
Auckland, New Zealand · Recruiting
Showing 40 of 58 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.